Project Grant HT94252510434
Award Date
7/1/25
Completion Date
6/30/28
Dollars Obligated
$728K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cold Spring Harbor, NY 11724, USA
Similar Awards
The U.S. Defense Health Agency (DHA) awarded a $518,342 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to Cold Spring Harbor Laboratory (CSHL) to support research on "Communication Between Cancer-Associated Fibroblasts and Neurons Promotes Pancreatic Cancer Progression." The grant, which runs from July 1, 2025 to June 30, 2028, will fund advanced biomedical research to investigate innovative approaches to the prevention, diagnosis, and treatment...
The Department of Defense's Defense Health Agency has awarded a $1,344,002 Project Grant to Cold Spring Harbor Laboratory (CSHL) under the Military Medical Research and Development program (CFDA 12.420). This four-year grant, running from August 1, 2024 to July 31, 2028, will fund research to enhance immunity in colorectal cancer liver metastases. CSHL, a renowned non-profit research institution, will leverage its expertise in cancer biology, genomics, and molecular biology to advance this...
The U.S. Department of Defense's Defense Health Agency awarded a $384,000 Project Grant to the Cold Spring Harbor Laboratory (CSHL) to study the impact of recurrent acute pancreatitis on macrophage heterogeneity and function. This grant, awarded under the Military Medical Research and Development program (CFDA 12.420), will fund research aimed at improving the health and care of military service members, veterans, and their families. The grant has a performance period from February 1, 2024 to...
The U.S. Department of the Army Medical Command awarded a $1,440,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to Cold Spring Harbor Laboratory (CSHL) to conduct research on "Targeting Hypothalamic Neurons to Abrogate Stress-Induced Breast Cancer Growth." The grant, which runs from March 1, 2025 to February 29, 2028, will support advanced biomedical research initiatives focused on transforming healthcare for military service...
The federal Project Grant award of $1,224,997.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Cold Spring Harbor Laboratory (CSHL) to conduct research aimed at "ENHANCING IMMUNITY IN COLORECTAL CANCER LIVER METASTASES." This grant, with a performance period from August 1, 2024 to July 31, 2028, will allow CSHL, a renowned non-profit research institution, to leverage its expertise in cancer biology, genomics,...
This federal Project Grant award of $708,000.00 provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research conducted by the Sloan-Kettering Institute for Cancer Research, a non-profit organization located in New York, NY. The research project is focused on investigating the "Prevalence and Biologic Impact of FGFR3 Genomic Alterations in Bladder Cancer". The 2-year award period runs from September 15, 2023 to...
The Department of the Army Medical Command awarded $1,394,002 to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420) on August 15, 2022 for a project grant with a completion date of August 14, 2025. Under this award, Cold Spring Harbor Laboratory and sub-awardees Weill Medical College of Cornell University will explore the relationship between sites of metastatic prostate cancer and the peripheral nerve system. Researchers will analyze human...
The federal Project Grant award of $923,805.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant will fund the "Systematic Functional Dissection of Cancer Cell States in Lung Tumors" research project at the Sloan-Kettering Institute for Cancer Research in New York, NY. The project aims to advance understanding of cancer cell biology and develop novel therapeutic approaches for lung cancer, with...
The Project Grant award of $352,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support the Sloan-Kettering Institute for Cancer Research in augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor for the treatment of glioblastoma. The award, with a performance period from September 1, 2025 to August 31, 2027, will enable Sloan-Kettering to conduct advanced biomedical research focused on transforming healthcare for...
The Department of the Army Medical Command awarded a $576,001 Project Grant to Cold Spring Harbor Laboratory to support research titled "Role of the Tumor Neuroenvironment in Prostate Cancer Metastasis." The two-year award running from August 1, 2022 to July 31, 2024 will fund research investigating the role of the tumor microenvironment in prostate cancer metastasis. This award is being made under the Military Medical Research and Development program (CFDA 12.420). This program...